Feb 20, 2019 / 03:55PM GMT
Michael James Leithead - Barclays Bank PLC, Research Division - Research Analyst
All right. So looks like the clock's running, so we'll go ahead and get started. So for those of you I haven't met, my name is Mike Leithead. I work on the U.S. Chemical's team with Duffy Fischer. We're happy to have Westlake here with us today. So we have Steve Bender, who is the Chief Financial Officer for Westlake and John Brennan, who's handling out some of the books, helps out with some of the IR function as well.
We'll go ahead and get started with some of the ARS questions first to knock those out in the beginning. So I guess, question one, and again, we'll use these little handsets that you have here. Do you currently own the stock, overweight, equal weight, underweight, no? No. Okay. An opportunity there.
Next question. What is your general bias towards the stock right now? One, positive; two, negative; three, neutral? Positive, pretty mixed.
Okay. Next question. In your opinion, through-cycle EPS growth for Westlake will be above peers, in line with peers, below peers? Above peers.
Westlake Chemical Corp at Barclays Industrial Select Conference Transcript
Feb 20, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers